title: Trend evaluation of aluminium in uraemic patients on chronic hemodialysis.
authors.forename: B R
authors.initials: BR
authors.lastname: Di Iorio
authors.forename: L
authors.initials: L
authors.lastname: Scarpino
authors.forename: A
authors.initials: A
authors.lastname: Bruno
authors.forename: A
authors.initials: A
authors.lastname: Confessore
authors.forename: G
authors.initials: G
authors.lastname: Gaudiano
authors.forename: C
authors.initials: C
authors.lastname: Altieri
authors.forename: F
authors.initials: F
authors.lastname: Smilari
authors.forename: D
authors.initials: D
authors.lastname: Papaleo
authors.forename: G
authors.initials: G
authors.lastname: Cosentino
authors.forename: V
authors.initials: V
authors.lastname: Terracciano
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000535:Aluminum / Q000097:blood*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D010281:Parathyroid Hormone; D000535:Aluminum